Arena Pharmaceuticals to Host Key Opinion Leader Event on Pulmonary Arterial Hypertension (PAH) on May 25 in New York City

SAN DIEGO, May 18, 2017 /PRNewswire/ — Arena Pharmaceuticals, Inc. (ARNA), today announced that it will host a key opinion leader (KOL) event for investors focused on the treatment of pulmonary arterial hypertension (PAH) in New York City on Thursday, May 25, from 8–9:30 a.m. EDT.